project
DePaul University
Department of Marketing
Driehaus College of Business
Center for Sales Leadership
Procter & Gamble / Walgreens Case
Spring 2020
Your Distributor
McKesson's Roots in Health Care Services
McKesson is the world's oldest and largest health care services company, providing pharmaceuticals, medical supplies and technology solutions that improve the quality of health care while reducing costs. McKesson people, products and solutions touch every facet of the health care system - from physicians and hospitals to pharmacies, payers and patients. This connective role in health care enables them to drive innovation and empower their customers to achieve their full potential.
The history of McKesson dates back to the beginnings of organized health care in the United States. Founded in 1833 by John McKesson and Charles Olcott in New York City, the company was focused on the importation and wholesaling of therapeutic drugs and chemicals from its inception.
Run out of a small shop in the city’s financial district, the business quickly began to thrive in an era when sailing ships were introducing America to a new world of global trade. McKesson and Olcott did a brisk business stocking the medicine chests aboard those ships, providing them with drugs imported from Europe and medicinal herbs, roots and spices acquired from Shaker colonies in Pennsylvania.
Soon the partners hired an assistant, Daniel Robbins, who within a few years would be made a partner himself. After Olcott’s death in 1853, the firm was renamed McKesson & Robbins. By then, the company was already distributing pharmaceutical products via covered wagons in 17 states and territories, from Vermont to California. In 1855, the company became one of the first wholesale houses to manufacture drugs. McKesson & Robbins' fluid extracts, tinctures, pills and tablets soon became known all over the world and the company won medals for its pioneering work.
The 20th Century: Expanding Horizons
In the early 1900s McKesson & Robbins made a critical strategic decision to persuade a number of well-established wholesaling firms to become its subsidiaries, forming a national drug wholesaling company. That move made McKesson & Robbins the leading distributor of pharmaceutical drug products in the United States. It also shifted the company's focus to distribution for various lines of businesses outside of health care.
During the 1960s, McKesson & Robbins continued its focus on distribution by merging with Foremost Dairies of San Francisco to form Foremost-McKesson Inc. The new company included four main operating units: McKesson & Robbins Drug Company, Foremost Foods Company, McKesson Liquor Company and McKesson Chemical Company. Foremost-McKesson became the largest U.S. distributor of drugs, alcoholic beverages and chemicals; the largest supplier of whey by-products; the largest producer of processed water; a leader in the fresh dairy products field; and a multiregional distributor of hospital and laboratory supplies and equipment.
In the 1980s and 1990s, McKesson decided to focus more on health care and divested its unrelated businesses such as Foremost Dairies, McKesson Chemical, McKesson Wine & Spirits and Armor All Products.
During this time, McKesson acquired Automated Healthcare, now part of McKesson Automation, and General Medical, the largest distributor of medical-surgical supplies. The company also acquired HBO & Company for $14 billion in stock and operated for a time as McKesson HBOC—the world's largest health care services company. In 2000, McKesson divested its only remaining non-health care asset, McKesson Water Products.
McKesson Today
Today, McKesson is ranked 15th on the FORTUNE 500 with more than $106.6 billion in annual revenue. The company delivers vital medicines, medical supplies and health care information technology solutions that touch the lives of patients in every health care setting. The depth and breadth of the company’s product and service offerings, coupled with the largest customer base in the health care industry, uniquely position McKesson to meet the needs of its customers:
· 200,000 physicians
· 26,000 retail pharmacies
· 10,000 long-term care sites
· 5,000 hospitals
· 2,000 medical-surgical manufacturers
· 750 homecare agencies
· 600 health care payers
· 450 pharmaceutical manufacturers
McKesson Corporation, currently ranked 15th on the FORTUNE 500, is the nation’s largest health care services company. McKesson is dedicated to helping its customers deliver high-quality health care by reducing costs, streamlining processes and improving the quality and safety of patient care. Over the course of its 176-year history, McKesson has grown by providing:
· Pharmaceutical supply management across the spectrum of care
· Medical-Surgical supplies to non-acute care sites
· Health care information technology for hospitals, physicians, homecare and payers
· Pharmacy automation
· Services for manufacturers and payers designed to improve outcomes for patients
Empowering the evolution of health care, McKesson’s products and services improve the quality of care, eliminate errors, reduce unnecessary costs, synthesize information for physicians, improve the workflow of nurses and free up pharmacists to counsel patients.
Your Customer
America's premier pharmacy
How did a neighborhood drugstore, founded in 1901 and measuring just 50 feet by 20 feet, become the pharmacy all others are measured by and one of the most respected American corporations?
It all started in a town called Dixon
It would be impossible to tell the story of Walgreens drugstores without telling the story of Charles R. Walgreen, Sr. the man who started it all. Walgreen was born near Galesburg, Illinois, before his family relocated to Dixon, Illinois - a town 60 miles north of his birthplace - when his father, a farmer turned businessman, saw the great commercial potential of the Rock River Valley. It was here that Walgreen, at the age of 16, had his first experience working in a drugstore, though it was far from a positive one. Working at Horton's Drugstore (for $4 a week) was a job he took only because of an accident that left him unable to take part in sports. While working in a local shoe factory, Walgreen accidentally cut off the top joint of his middle finger, ending his athletic competition. Were it not for the accident, Walgreen might never have become a pharmacist, business owner and phenomenally successful entrepreneur. Ironically, his initial experience working at Horton's was itself a failure. Walgreen left after just a year and a half on the job.
Still, Walgreen realized that his future lay not in Dixon, but in a far larger city — Chicago.
Chicago in 1893, the year of Walgreen's arrival, was far from promising for a future drugstore entrepreneur. More than 1,500 drugstores already competed for business (many extremely successful) and customers had no lack of choice. Given this stiff competition, Walgreen's ultimate achievements are all the more remarkable.
A lesson well learned - and never forgotten - by Walgreen
In a series of jobs with Chicago's leading pharmacists - Samuel Rosenfeld, Max Grieben, William G. Valentine and, most importantly, Isaac W. Blood - Walgreen grew increasingly knowledgeable - and increasingly dissatisfied - with what he saw as old-fashioned, complacent methods of running a drugstore. Where was the desire to provide superb customer service? Where were the innovations in merchandising and store displays? Where was the selection of goods that customers really wanted and could afford? Where was the sense of trying to understand, please and serve the many needs of drugstore customers? And, most of all, where was the commitment to providing genuine value to the customer?
The answer was obvious: Walgreen had to open his own pharmacy.
However, it was not until 1901 that Walgreen was able to put together enough money for the down payment on his pharmacy. He wanted to buy the store in which he was working, owned by Isaac Blood. Walgreen had been not only a trusted employee, but a valuable business advisor as well. Yet even in view of Walgreen's outstanding business counsel on Blood's behalf, Blood was unyielding in the sale to Walgreen, raising his asking price from $4,000 to $6,000. Though it would take years for Walgreen to pay off the loan he signed for the purchase, he went ahead. He was now his own man and well on his way to building one of the most remarkable businesses in America.
By every account, Walgreen succeeded brilliantly, simply by practicing what he preached and instituting what he felt were clearly needed innovations. New, bright lights were installed to create a cheerful, warm ambiance in the store. Each customer was personally greeted by Walgreen or his colleague, Arthur C. Thorsen. Aisles were widened, creating a spacious, airy, welcoming feeling - a far cry from the cramped interiors of other drugstores. The selection of merchandise was improved and broadened, including pots and pans (unheard of in a drugstore!) at the bargain price of 15¢ a piece! Prices were kept fair and reasonable. The quality of Walgreen's pharmaceutical compounds (he had become a registered pharmacist in 1897) met the very highest standards for purity and freshness. Efficiency was increased. But the most dramatic change Walgreen instituted was a level of service and personal attention unequaled by virtually any other pharmacy in Chicago.
The year was 1910. Walgreen now had two stores. His challenge: how to find ever-new ways of satisfying a growing customer base while outshining his competitors. Over the preceding 100 years, the soda fountain had become key to virtually every American drugstore. Beginning in the early 19th century, bottled soda water, and later charged soda water, were considered important health aids, making it a natural fixture in drugstores. Manufacturers vied in creating ornate fountains, with onyx counter-tops and fixtures of silver and bronze and lighting by Tiffany. Walgreens® was no exception to such a popular trend. Indeed, its soda fountains were among Chicago's most beautiful. Yet the reality was that the items soda fountains served - ice cream and fountain creations - were invariably cold. And cold items sold only in hot weather. That meant each fall drugstore owners everywhere were resigned to mothballing their soda fountains until the warm weather returned. Thus, the drugstores lost an important revenue stream, not to mention valuable store space that could have been used for other, profitable purposes.
Why not serve hot sandwiches?
Beginning with simple sandwiches, soups and desserts, Walgreen was able to keep his fountain open during the winter and provide his customers with affordable, nutritious, home-cooked meals. As a result of this common-sense innovation, Walgreen once again demonstrated his knack for helping his company while better serving the public. From then on, through the 1980s, food service was an integral part of the Walgreens story. Every Walgreens® was outfitted with comfortable, versatile soda fountain facilities serving breakfast, lunch and dinner. Just as Walgreen had reasoned, customers coming to the stores for food usually stayed to purchase other necessary items. And with its friendly waitresses, wholesome food and fair prices, loyalty to Walgreens increased exponentially.
By 1913, Walgreens® had grown to four stores, all on Chicago's South Side. The fifth Walgreens® opened in 1915 and the ninth in 1916. By 1919, there were 20 stores in the rapidly-growing chain.
As impressive as this growth was, even more impressive was the superb management team that Walgreen had begun to assemble since his second store opened. Walgreen would often say - without any show of false modesty - that one of his greatest talents was his ability to recognize, hire and promote people that he considered smarter than he was. In his ability to spot talent, Walgreen was rarely wrong. In fact, his uncanny ability to hire extended even as far as the people who manned his soda fountain, including the man who created Walgreen's next sensation.
By 1920, now 20 stores strong and growing quickly, Walgreens® was an established fixture on Chicago's retail scene. Throughout this decade, Walgreens® underwent phenomenal growth. By 1929, the total number of Walgreens® stores reached 525, including locations in New York City, Florida and other major markets. Many factors contributed to this unprecedented growth: a superb management team, modern merchandising, innovative store design, fair pricing, outstanding customer service and exceedingly high pharmacy quality and service. Yet, one can't overlook something that may have seemed a minor innovation at the time. This was the invention of Walgreens® immortal malted milkshake, an instant classic, by Ivar "Pop" Coulson in 1922.
Response could not have been stronger if Coulson had found a cure for the common cold! His luscious creation was adopted by fountain managers in every Walgreens® store. It was written about in newspapers and talked about in every city where there was a Walgreens®. But most of all, it was the object of much adoration. It was not at all unusual to see long lines outside Walgreens® stores and customers stand three and four deep at the fountain waiting for the new drink. Suddenly, "Meet me at Walgreens® for a shake and a sandwich" became bywords as popular as "Meet me under the Marshall Fields' clock" at State and Randolph in Chicago.
So, once again, Charles Walgreen's prediction that his soda fountain would be absolutely essential to his stores as a source of revenue, company growth and increased customer satisfaction (which translated into even higher levels of customer loyalty and patronage) came true. In its own way, Coulson's malted was the fuel for Walgreens dramatic growth.
Surviving - and conquering - the Great Depression
By 1930, Walgreens® had well over 500 stores and quickly was becoming the nation's most prominent drugstore chain.
Throughout this period, Walgreens® continued to innovate. It had already become convinced of the value of advertising and remained one of the biggest newspaper advertisers in Chicago as well as other parts of the country. In fact, Walgreens® ran the largest promotion campaign in its history - costing more than $75,000 - during 1931. Perhaps even more significant was Walgreens® entry into broadcast advertising. Also in 1931, Walgreens® became the first drugstore chain in the country to advertise on radio, with legendary Chicago Cubs announcer Bob Elson as the "voice" of Walgreens ®.
Walgreens® expanded its line of high-quality, private label, value-packed items, from sundries and over-the-counter remedies to the hugely popular "Peau Doux" (pronounced "Po Do") golf balls, talc and other products. As a result Walgreens® saw consistent sales growth during the Depression years. In fact, so confident was Walgreen of his country and his company, he erected a brand-new building to serve as Walgreens® state-of-the art warehouse/distribution center for stores in the greater Chicago area.
From the 1940s to today, the story of Walgreens® is the story of a company that has never rested on its laurels, finding ever-new ways to satisfy its customers and stay ahead of the curve in operating its business. With Walgreen’s insistence on innovation and commitment to customers, growth and prosperity lay ahead. By 1975, more than 1,500 pharmacists in 633 stores filled close to 30 million prescriptions annually, four times the 7.5 million dispensed in 1962 and five million more than in 1972.
Walgreens® today
By 1984, Walgreens® opened its 1,000th store - and today, with 425 new stores opening each year and 7,000 planned by 2010, Walgreens continues to innovate. Walgreens® new computer system for filling prescriptions, Intercom Plus, links all stores into a single network and represents how advanced technology serves customers' needs better than any other pharmacy resource. In fact, Walgreens® is the largest private user of satellite technology (second only to the United States government). Billing, labeling and prescription histories (for tax planning and reimbursement) are available more quickly and easily than ever before.
At the end of the 2009 fiscal year, Walgreens® reported annual sales of $63.3 billion (up 7.3% from the prior year), and earnings of $2.01 billion (down 7.3% from the prior year). Prescriptions account for 66% of Walgreens sales.
Your Company
The World's Brand Expert
Since 1837, P&G has built a rich heritage of touching consumers’ lives with brands that make life a little better every day. This simple purpose has enabled them to become one of the world’s leading consumer products companies—and will continue to guide them as they seek to improve lives now and for generations to come.
The Strength of P&G
P&G focuses on five core strengths required to win in the consumer products industry:
Consumer understanding
No company in the world has invested more in consumer and market research than P&G. P&G interacts with more than five million consumers each year in nearly 60 countries around the world, and conducts over 15,000 research studies every year. P&G invests more than $350 million a year in consumer understanding. This results in insights that tell them where the innovation opportunities are and how to serve and communicate with consumers.
Innovation
P&G is the innovation leader in our industry. Virtually all the organic sales growth delivered in the past nine years has come from new brands and new or improved product innovation. More than half of all product innovation coming from P&G today includes at least one major component from an external partner. The IRI New Product Pacesetter Report ranks the best-selling new products in our industry in the U.S. every year. Over the past 14 years, P&G has had 114 top 25 Pacesetters—more than their six largest competitors combined. In the last year alone, P&G had five of the top 10 new product launches in the U.S. and 10 of the top 25.
Brand-building
P&G is the brand-building leader of the industry. They have built the strongest portfolio of brands in the industry with 22 billion-dollar brands and 19 half-billion-dollar brands. Eleven of the billion-dollar brands are the #1 global market share leaders of their categories. The majority of the firms are #2 in their categories.
Go to Market Capabilities
P&G is consistently ranked by leading retailers in industry surveys as a preferred supplier and as the industry leader in a wide range of capabilities including clearest company strategy, brands most important to retailers, strong business fundamentals and innovative marketing programs.
Scale
Over the decades, P&G has established significant scale advantages as a total company and in individual categories, countries and retail channels. P&G’s scale advantage is driven as much by knowledge-sharing, common systems and processes, and best practices as it is by size and scope. These scale benefits enable them to deliver consistently superior consumer and shareholder value.
The P&G Brands
P&G's portfolio is led by 22 billion-dollar brands, focused in three broad categories - Beauty and Grooming, Health and Well Being, and Household Care. Brands in the billion dollar category include:
Actonel® (osteoporosis drug)
Bounty® (paper towel), Braun® (small-appliances)
Crest® (toothpaste and teeth whitening)
Duracell® (batteries and flashlights)
Fusion® (men's wet shave razors)
Gain® (laundry detergent and fabric softeners)
Gillette® (safety razor and male grooming)
Head & Shoulders® (shampoo and conditioners)
Old Spice® (aftershave, deodorants, soaps and body wash)
Ivory® (soap)
Oral-B® (toothbrush and oral care)
Pampers® (disposable diaper and baby care)
Prilosec® (heartburn medicine)
Pringles® (potato chips)
Secret® (antiperspirant and deodorant)
TAG® (deodorant and body spray)
Tide® (laundry detergent)
Vicks® (over-the-counter medicines - Formula 44®, Sinex®, NyQuil®/DayQuil®)
Wella® (hair care products)
Whisper® (pantyliners)
Financial Results
Working hard to stay in touch with the consumers who use their products, P&G reported sales of $79.0 billion (down 3.3% from the prior year) and earnings of $13.4 billion (up 10.7% from the prior year) in fiscal 2009.
The Challenge
The Vicks® NyQuil® and DayQuil® Cold and Flu Multi-Symptom Relief products are the leading cold remedy product sold in the US market and in many markets world-wide.
Winter means flu, and flu encourages sufferers to give their colds to Contac®, or Dristan®, or NyQuil®, or Comtrex®, along with other pills, tablets and liquids in the $5.0 billion cold remedy market.
"This market is very dependent on the level of winter nastiness,'' said Neil B. Sweig, an analyst at Shearson®/American Express®. ''Last February-March, we had widespread flu, and cold remedy sales in that period were up 21 percent. Now we are having a much colder December-January this year than we had last year, and that bodes well for this market.''
But, while cold remedies as a group have been outselling items such as shampoo, toothpaste and aspirin individually for several years, the industry has had trouble growing. Advertising spending of more than $500 million a year has not been able to result in significantly larger amounts of medication down the throats of the afflicted.
''Based on research by A.C. Nielsen, 51% of consumers do not use cold and flu products, because they cannot find their brand in stock at the exact time that they need it - identical to the percentage that do not keep a regular supply of cold and flu products in their medicine cabinet inventory. If it is not readily accessible, they will not purchase the products, since the cold and flu are usually gone within three to seven days.'' said Mr. Sweig.
''It's a marketing game,'' said Peter B. Robb, an analyst at Merrill Lynch, Pierce, Fenner & Smith Inc. ''New improved products, or product line extensions supported by heavy advertising, are the ones that make the most headway.
In the scramble for market share, manufacturers have recently introduced a number of new products - Vicks® Headway®, for example - but none have enjoyed the spectacular success of Comtrex®.
Comtrex®, a Bristol-Myers Company product, arrived on retail shelves in the last quarter and propelled itself into third place almost immediately, selling $750 Million within only a few years.
But the undisputed leader in cold remedies is Richardson-Vicks with its NyQuil®, a nighttime liquid cold medication, and its line of Vicks® products. According to Mr. Robb, the company has a market share of slightly more than 31 percent of the cold remedy market, with sales last year of $1.55 Billion.
Close on its heels is Contac®, marketed by Menley & James, a SmithKline® subsidiary, with about a $900 Million, Comtrex® ranks third and No.4 is Dristan®, from American Home Products Corporation, which has roughly 12 percent, according to Mr. Sweig.
The remainder of the cold remedy market seems to be divided between brands such as CoTylenol®, from the McNeil Consumer Products division of Johnson & Johnson, and Alka-Seltzer Plus® Cold Medicine from Miles Laboratories (with a 10% and 5% share respectively), as well as private-label brands from major drugstore chains.
Sharply defined marketing trends have emerged since the entry of Comtrex®, which was the first remedy to carve out a multi-symptom relief niche.
''Comtrex® looked at an untapped market and found people who wanted to take one pill that would clear up their noses and throats and sinuses all at once,'' said Mr. Sweig, at Shearson/American Express®.
Comtrex® was introduced with a network television ad campaign that showed a medicine cabinet spilling over with pills and bottles on one side, and a lone container of Comtrex® on the other. The ads worked and others (including NyQuil®) quickly picked up on the multi-symptom approach.
In comparison, Contac®, with its time-release capsules, staked out its territory in 1961 and has owned it ever since. ''There are no significant competitors to Contac® in the sustained release field,'' said William P. Howe 3d, vice president and director of marketing for Menley & James.
It remains to be seen whether the new entries will open up more of the market, or simply steal market share from their predecessors. ''There's an increasing trend toward self-medication, as doctors' fees and prescription drug prices have risen enormously over the past 10 years,'' said a spokesman at Richardson-Vicks, citing a 141 percent rise in prescription drug prices over the past ten years. ''New entries create additional competition, but they also help expand the market.''
In a strategy meeting with the marketing department, you (as VP of Sales for P&G's Health and Well Being - Worldwide) have pointed out three critical areas which limit P&G's ability to gain maximum benefit from the cold and flu season onset every year:
· Knowing when the cold/ flu season starts (and its severity) in specific areas
· Time lag between start, consumer reaction, retailer orders, and advertising
· Time lag between retailer shipment, and in-store display placement
You have recommended this year that the company test a special promotion to supplement the normal pre-ordering and shipments with your largest account - Walgreens® - using a special "Just in Time" distribution effort to provide incremental sales and margin during the season, which would consist of the following steps:
· Engage the Gallup® organization to set up an "early-bird" warning system with public schools which would compensate the schools $1,000 per month (3 schools in each of the top 100 markets) for a period of 3 months to report absenteeism (flu-days) on a weekly basis. This data would be used to trigger additional display shipments to retailers, as well as initiate pre-planned higher levels of television advertising on a market-by-market basis.
· Engage McKesson to stock and supply special displays prior to the season, which can then be delivered in 24 hours to key retail locations. P&G would ship the product 30 days in advance of the expected season to McKesson, and would provide terms of Net 60 days from date of shipment to Walgreens® stores. McKesson would be paid a fixed percentage of the retailer cost of the display of 10% for storage, distribution, shipping, and set-up under the program.
· Engage Walgreens® to commit in advance to automatic orders to be placed and shipped at the start of the season for special displays (over their normal seasonal stocking levels), and commit to multiple displays for a period of 60 days. P&G would provide terms of 60 days from date of shipment from McKesson to the retailer on the displays, as well as a 5% discount on the display merchandise only.
The season sales history of NyQuil® indicates that roughly 70% of the sales occur in the 1st (Jan-Mar and 4th (Oct-Dec) period, and the remainder "off-season". Your early talks with retailers indicated that they feel that they can increase sales by 25% in the 6 month period over normal levels if they have a timelier in-stock situation, as well as higher consumer awareness at the appropriate time.
The special display will feature the following products in the NyQuil® and DayQuil® brands:
In an earlier meeting with one of the Walgreens® buyers, you shared the following initial analysis of the pricing and gross margin positions for both Walgreens® and P&G® related to the specific details of the promotion.
The only products which will be in the special display are NyQuil® in liquid (single and
double pack), and NyQuil®/DayQuil® LiquiCaps (double pack) as follows:
NyQuil® NyQuil® NyQuil®/DayQuil® Combo
Product Description (10oz) (2-10oz) 40 Count LiquiCaps
Retail price (SRP) $7.09 $13.59 $12.69
Retailer cost of goods $4.99 $9.69 $8.85
Retailer gross margin 29.6% 28.7% 30.26%
Vick's cost of goods $1.15 $2.40 $2.75
Vicks gross margin 77.0% 75.2% 68.9%
Number of each per display 72 144 84
Additional expense for special $25.00/display
NyQuil® cardboard shipping
carton and in-store display
(P&G pays this cost)
In order to provide an incentive to Walgreens® for taking on the additional merchandise and pre-committing to take at least three displays per store per month during the season (9 per store), P&G® is offering Walgreens® the special Net 60-day terms and the 5% discount from the normal prices on the display merchandise. No return goods will be allowed at the end of the season, as Walgreens® can "break-up" the displays and place the merchandise on the shelf - since they already stock and sell these items all year long.
Additionally, as compensation for the stocking and shipping of the displays, McKesson® will be paid 10% of the retailer cost of goods on each display to cover stocking, storage, and final shipping and display set up at the store level.
During another presentation of this new program to Walgreens® yesterday, you shared the initial financials with four more influencers/customer contacts (all of whom you have had some contact with in the past):
· Charles Schultz – Category Manager
· Frank Novello – Pharmacy Manager, Health Outcomes and Reports
· Julie Heart – Promotions Manager
· Fred Grayda – Financial Analyst
You were fortunate to have a new intern with you during the presentation who took notes of the conversations. From his notes, it appears Walgreens® is interested in the promotion, but needs to better understand the details of the programs and how it will impact their margins and operation. The people in this meeting had not seen the initial financial proposal that you quickly reviewed with the other buyer so there were a number of questions. Based on the feedback from these four, you have set up another meeting with them next week to present the final proposal to Walgreens®. The meeting is only six days away, but you and your P&G® sales and marketing colleagues are used to creating winning presentations that monetize your marketing strategy with tight timing.
Transcript from yesterday’s meeting with Walgreens®:
You: Good morning! It's a pleasure to see you all again, and I appreciate you taking time out to discuss a new promotion with Walgreens® for Vicks® NyQuil® and DayQuil® for this cold and flu season.
Charles: We appreciate the fact that you want to partner with Walgreens® to test this promotion, and are anxious to hear more - especially since a number of the people in this meeting have not heard all of the details.
We've got some aggressive sales targets from management this year, and we need all the help we can get to increase revenue and profit in our stores.
As you know, the pharmacy section generates nearly two-thirds of our profit at Walgreens®.
If you can show us a way to increase our profitability and sales levels over last year, we're interested - we've just been put on an entirely new bonus system - and it's based on increases over last year on a store- by-store basis in profit margin.
You: Frankly, I'm here to get your reactions, rather than a firm commitment today - so that we can come back to you with a custom designed idea which meets your needs - and we would like to hear your thoughts on the value of display promotions - pro and con - from each of your individual responsibility areas.
Frank: Good idea - frankly they're (excuse my language) a "real pain in the ass". We never seem to get the needs right, they take up an enormous amount of space in the distribution center, and we always seem to get "stuck" with too much inventory at the end of the promotion that we don't normally carry. Then we have to sell if off at a discount. I just don't see the upside from a special promotion from our standpoint, especially since our last one bombed, and I really got chewed out for not being able to deliver the product to the stores on time.
You: I certainly understand the distribution problems. If I'm hearing you right, a promotion which would eliminate handling through your distribution center would be the best outcome for your group?
Frank: Frankly, yes - but I don't know what others on the team feel about that concept.
Julie: As Promotions Manager, it goes a little deeper than that - we need to have displays of only the highest share products, since we don't want to end up with excess inventory - and on a seasonal basis, the money that we have to tie up pre-season is huge in
terms of the amount of inventory that we have to carry to ensure that we are ready when the season starts.
I'm concerned that we'll have a disaster like last year, when we promoted the new product from American Home Products. Since the consumers were not aware of it, we had that product all the way through June, when we had paid for it in October. Since I'm responsible for the store display and promotion program, I'll definitely need to see the probability of incremental sales and margin at the store level. And it can't include any items that we don't carry - too many companies see one-time promotions as a way to add SKU's to the store.
Fred: One of the things that we'll want to see is the ROI on the promotion. Since finance has intruded on the art of promotions in our company, we have to give them numbers for everything. As the finance member of this buying team, I will definitely need to see that before we can approve anything. I need a way to make the financial guys happy!
You: Since this is a test, it will be limited to Walgreens® for this first season - does that have additional appeal?
Charles: Absolutely - as you know, we're the best drugstore chain in America - but we need better promotions. Osco Drug always seems to have great promotions, and I'm pretty damned tired of being second to them in this area!
Julie: I actually like the idea, and think it will greatly increase our sales by keeping us in stock, but I don't want to be the one to tell management that the promotion left us with a ton of product at the end of the season! I think that we would be smart to exclude the 20% of stores that had a poor performance last season due to the fact that they are in warmer climates that do not have the dramatic temperature change. I'm pretty proud of the work we've done this year, and wouldn't want it to end in a disaster.
Frank: If you can show me how you can do it without involving the distribution centers - I'm on your side. Frankly, I'm pretty
upset about the promotions group always thinking that
our space and capacity for shipping is unlimited.
You: Our initial market research has shown some very interesting data regarding when and why people purchase cold and flu products, and I'll review that with you at the next meeting.
Thanks to you, I think that we've got some good ideas to help you increase your sales and margin, while limiting the risk and pain that usually comes with short term promotions.
I know that you are all anxious to look at the final sales and margin impact of the test program, and see the operating details. I'll get right on the analysis required to demonstrate the value of this promotion to your bottom line! We’ll be back next Wednesday to
present the details.
2
3